The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has made a serious public health …

Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …

Recently emerged SARS-CoV-2 caused a major outbreak of coronavirus disease 2019
(COVID-19) and instigated a widespread fear, threatening global health safety. To date, no …

Abstract Novel coronavirus (COVID-19) is started from Wuhan (City in China), and is rapidly
spreading among people living in other countries. Today, around 215 countries are affected …

Favipiravir (FVP), a pyrazine analog, has shown antiviral activity against a wide variety of
viruses. It is considered to be worth further investigation as a potential candidate drug for …

The entry of SARS-CoV-2 into target cells requires the activation of its surface spike protein,
S, by host proteases. The host serine protease TMPRSS2 and cysteine proteases Cathepsin …

The outbreak of novel coronavirus disease (COVID-19) has claimed millions of lives and has
affected all aspects of human life. This paper focuses on the application of deep learning …

The SARS-CoV-2 was confirmed to cause the global pandemic of coronavirus disease 2019
(COVID-19). The 3-chymotrypsin-like protease (3CLpro), an essential enzyme for viral …

RESUMEN Introducción: La Organización Mundial de la Salud declaró desde el 11 de
marzo de 2020 la infección por el coronavirus denominado SARS-CoV-2, como una …

The ongoing pandemic of Coronavirus disease (COVID-19) emerged in Wuhan, China in
the end of 2019. It has already affected more than 300,000 people, with the number of …